Immune-mediated reactions to vancomycin A systematic case review and analysis

Annals of Allergy, Asthma and Immunology

Volumn 116, Issue 6, 2016, Pages 544-553

  Minhas, Jasmit S ^a   Wickner, Paige G ^b,c   Long, Aidan A ^c,d   Banerji, Aleena ^c,d   Blumenthal, Kimberly G ^c,d  

^a LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANTIHISTAMINIC AGENT; CYCLOSPORIN; MYCOPHENOLATE MOFETIL; STEROID; VANCOMYCIN; ANTIINFECTIVE AGENT; IMMUNOGLOBULIN E;

ANAPHYLAXIS; ANTIBIOTIC THERAPY; BULLOUS SKIN DISEASE; DRESS SYNDROME; DRUG FATALITY; DRUG HYPERSENSITIVITY; DRUG WITHDRAWAL; HUMAN; IMMUNE COMPLEX NEPHRITIS; IMMUNOPATHOLOGY; INFORMATION RETRIEVAL; INTERSTITIAL NEPHRITIS; LINEAR IGA BULLOUS DERMATOSIS; MEDLINE; MORTALITY; PRIORITY JOURNAL; REVIEW; STEVENS JOHNSON SYNDROME; SYSTEMATIC REVIEW; TOXIC EPIDERMAL NECROLYSIS; ADULT; AGED; CASE REPORT; CHEMICALLY INDUCED; FEMALE; IMMUNOLOGY; MALE; MIDDLE AGED; STEVENS-JOHNSON SYNDROME; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ANAPHYLAXIS; ANTI-BACTERIAL AGENTS; DRUG HYPERSENSITIVITY; FEMALE; HUMANS; IMMUNOGLOBULIN E; MALE; MIDDLE AGED; NEPHRITIS, INTERSTITIAL; SKIN DISEASES, VESICULOBULLOUS; STEVENS-JOHNSON SYNDROME; VANCOMYCIN; YOUNG ADULT;

EID: 84964811651     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/j.anai.2016.03.030     Document Type: Article

References (89)

1. E. Rubinstein, and Y. Keynan Vancomycin revisited - 60 years later Front Public Health 2 2014 217
2. M. Rybak, B. Lomaestro, J.C. Rotschafer, and et al. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists Am J Health Syst Pharm 66 2009 82 98
3. D.W. Bratzler, E.P. Dellinger, K.M. Olsen, and et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery Am J Health Syst Pharm 70 2013 195 283
4. R. Bruniera The use of vancomycin with its therapeutic and adverse effects: a review Eur Rev Med Pharmacol Sci 2015 694 700
5. M. Wynn, J.R. Dalovisio, A.D. Tice, and X. Jiang Evaluation of the efficacy and safety of outpatient parenteral antimicrobial therapy for infections with methicillin-sensitive Staphylococcus aureus South Med J 98 2005 590 595
6. S. Sivagnanam, and D. Deleu Red man syndrome Crit Care 7 2003 119 121
7. A. Liberati, D.G. Altman, J. Tetzlaff, and et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration PLoS Med 6 2009 e1000100
8. M.E. Weiss, D.I. Bernstein, J. Blessing-moore, and et al. Drug allergy: an updated practice parameter Ann Allergy Asthma Immunol 105 2010 259 273
9. Weller PF. Vancomycin hypersensitivity. UpToDate. http://www.uptodate.com/contents/vancomycin-hypersensitivity. Accessed August 10, 2015.
10. I.M. Otani, J. Kuhlen Jr., K. Blumenthal, and A.B. Guyer A role for vancomycin epicutaneous skin testing in the evaluation of perioperative anaphylaxis J Allergy Clin Immunol Pract 3 2015 984 985
11. R.L. Campbell, J.T.C. Li, R.A. Nicklas, and A.T. Sadosty Emergency department diagnosis and treatment of anaphylaxis: a practice parameter Ann Allergy Asthma Immunol 113 2014 599 608
12. Joint Task Force on Practice Parameters; American Academy of Allergy, Asthma and Immunology; American College of Allergy, Asthma and Immunology; Joint Council of Allergy, Asthma and Immunology Drug allergy: an updated practice parameter Ann Allergy Asthma Immunol 105 2010 259 273
13. A. Jingu, J. Fukuda, A. Taketomi-Takahashi, and Y. Tsushima Breakthrough reactions of iodinated and gadolinium contrast media after oral steroid premedication protocol BMC Med Imaging 14 2014 34
14. C.L. Renz, J.D. Thurn, H.A. Finn, J.P. Lynch, and J. Moss Antihistamine prophylaxis permits rapid vancomycin infusion Crit Care Med 27 1999 1732 1737
15. V. Mezzano, P. Giavina-Bianchi, M. Picard, J. Caiado, and M. Castells Drug desensitization in the management of hypersensitivity reactions to monoclonal antibodies and chemotherapy BioDrugs 28 2014 133 144
16. P.E. Hesterberg, A. Banerji, E. Oren, and et al. Risk stratification for desensitization of patients with carboplatin hypersensitivity: clinical presentation and management J Allergy Clin Immunol 123 2009 1262 1267
17. M.C. Castells Guitart Rapid drug desensitization for hypersensitivity reactions to chemotherapy and monoclonal antibodies in the 21st century J Investig Allergol Clin Immunol 24 2014 72 79
18. D. Bosse, C. Lemire, J. Ruel, A.M. Cantin, L. Valiquette, and F. Me Severe anaphylaxis caused by orally administered vancomycin to a patient with Clostridium difficile infection Infection 41 2013 579 582
19. R. Kupstaite, and E. Kaduševi Severe vancomycin-induced anaphylactic reaction Medicina (Kaunas) 46 2010 30 33
20. T. Kitazawa, Y. Ota, N. Kada, Y. Morisawa, and A. Yoshida Successful vancomycin desensitization with a combination Intern Med 45 2005 317 321
21. H. Hassaballa, N. Mallick, and J. Orlowski Vancomycin anaphylaxis in a patient with vancomycin-induced red man syndrome Am J Ther 7 2000 320
22. N. Chopra, J. Oppenheimer, G.S. Derimanov, and P.L. Fine Vancomycin anaphylaxis and successful desensitization in a patient with end stage renal disease on hemodialysis by maintaining steady antibiotic levels Ann Allergy Asthma Immunol 84 2000 633 635
23. A. Villavicencio, L. Hey, D. Patel, and P. Bressler Acute cardiac and pulmonary arrest after infusion of vancomycin with subsequent desensitization J Allergy Clin Immunol 100 1998 853 854
24. R.E. Polk, D.P. Healy, L.B. Schwartz, D.T. Rock, M.L. Garson, and K. Roller Vancomycin and the red-man syndrome: pharmacodynamics of histamine release J Infect Dis 157 1988 502
25. R. Kakar, H. Paugh, and C. Jaworsky Linear IgA Bullous Disease Presenting As Toxic Epidermal Necrolysis: A Case Report And Review Of The Literature Dermatology 227 2013 209 213
26. P.K. Selvaraj, and F.A. Khasawneh Linear IgA bullous dermatosis: a rare side effect of vancomycin Ann Saudi Med 33 2013 397 399
27. R. Jawitz, K. Kent, and B. Schapiro A vesiculobullous eruption in a hospitalized patient: diagnosis: drug-induced linear IgA bullous dermatosis (LAD) with eosinophils Arch Dermatol 147 1443 2011 1448
28. M. O'Brien, A. Shah, and H.B. Allen A pentad of vancomycin reactions Skinmed 9 2011 225 229
29. H.C. McDonald, N.R. York, and A.G. Pandya Drug-induced linear IgA bullous dermatosis demonstrating the isomorphic phenomenon J Am Acad Dermatol 62 2010 897 898
30. S. Walsh, K. Kerchner, and O.P. Sangüeza Localized palmar vancomycin-induced linear IgA bullous dermatosis occurring at supratherapeutic levels JAMA Dermatol 145 2009 603 604
31. I. Khan, R. Hughes, S. Curran, and P. Marren Drug-associated linear IgA disease mimicking toxic epidermal necrolysis Clin Exp Dermatol 34 2008 715 717
32. S. Senanayake, D. Hardman, and A. Mill Case of vancomycin-induced linear immunoglobulin A bullous dermatosis Intern Med J 38 2008 607
33. S.E. Billet, K.R. Kortuem, and L.E. Gibson A morbilliform variant of vancomycin-induced linear iga bullous dermatosis Arch Dermatol 144 2008 774 778
34. D. Navi, D.J. Michael, and N. Fazel Drug-induced linear IgA bullous dermatosis Dermatol Online J 8 2006 12
35. M.A. Waldman, D.R. Black, and J.P. Callen Vancomycin-induced linear IgA bullous disease presenting as toxic epidermal necrolysis Clin Exp Dermatol 29 2004 633 636
36. S. Joshi, G. Scott, and R.J. Looney A successful challenge in a patient with vancomycin-induced linear IgA dermatosis Ann Allergy Asthma Immunol 93 2004 101 103
37. A.W. Armstrong, A. Fazeli, S.W. Yeh, B.T. Mackool, and V. Liu Vancomycin-induced linear IgA disease manifesting as bullous erythema multiforme J Cutan Pathol 31 2004 393 397
38. R.P. Dellavalle, J.M. Burch, S. Tayal, L.E. Golitz, J.E. Fitzpatrick, and P. Walsh Vancomycin-associated linear IgA bullous dermatosis mimicking toxic epidermal necrolysis J Am Acad Dermatol 35 2003 56 57
39. B.I. Neughebauer, G. Negron, S. Pelton, R.W. Plunkett, E.H. Beutner, and R. Magnussen Bullous skin disease: an unusual allergic reaction to vancomycin Am J Med Sci 323 2002 273 278
40. R. Palmer, G. Ogg, J. Allen, and et al. Vancomycin-induced linear IgA disease with autoantibodies to BP180 and LAD285 Br J Dermatol 145 2001 816 820
41. P.A. Klein, and P. Jeffrey Drug-induced linear IgA bullous dermatosis after vancomycin discontinuance in a patient with renal insufficiency J Am Acad Dermatol 42 2000 316 323
42. M.Z. Mofid, C. Costarangos, B. Bernstein, L. Wong, A. Munster, and H.C. Nousari Drug-induced linear immunoglobulin A bullous disease that clinically mimics toxic epidermal necrolysis J Burn care Rehabil 21 2000 246 247
43. A.G. Danielsen, and K. Thomsen Vancomycin-induced linear IgA bulluous disease Br J Dermatol 141 1999 747 776
44. E.F. Bernstein, and M. Schuster Linear IgA bullous dermatosis associated with vancomycin Ann Intern Med 129 1998 508 510
45. H. Nousari, C. Costarangos, and G.J. Anhalt Vancomycin-associated linear IgA bullous dermatosis Ann Intern Med 129 1998 506 510
46. J.M. Whitworth, I. Thomas, S.A. Peltz, and et al. Vancomycin-induced linear IgA bullous dermatosis (LABD) J Am Acad Dermatol 34 5, pt 2 1996 890 891
47. S.S. Richards, S. Hall, B. Yokel, and S.E. Whitmore A bulluous eruption in an elderly woman Arch Dermatol 131 1995 1447 1448
48. C. Geissmann, M. Beylot-Barry, M.S. Doutre, and C. Beylot Drug-induced linear IgA bullous dermatosis J Am Acad Dermatol 32 2, pt 2 1995 296
49. M.K. Kuechle, E. Stegemeir, B. Maynard, L.E. Gibson, K.M. Leiferman, and M.S. Peters Drug-induced linear IgA bullous dermatosis: report of six cases and review of the literature J Am Acad Dermatology 30 1994 187 192
50. S. Carpenter, D. Berg, N. Sidhu-Malik, R.P. Hall III, and M.J. Rico Vancomycin-associated linear IgA dermatosis: a report of three cases J Am Acad Dermatol 26 1 1992 45 48
51. L.A. Baden, C. Apovian, M.J. Imber, and J.S. Dover Vancomycin-induced linear IgA bullous dermatosis Arch Dermatol 124 1988 1186 1188
52. S. Young, S. Ojaimi, H. Dunckley, and et al. Vancomycin-associated drug reaction with eosinophilia and systemic symptoms syndrome Intern Med J 44 2014 694 696
53. E. Della-Torre, M.-R. Yacoub, P. Pignatti, and et al. Optimal management of DRESS syndrome in course of infectious endocarditis Ann Allergy Asthma Immunol 110 2013 303 305
54. K.G. Blumenthal, S.U. Patil, and A. Long The importance of vancomycin in drug rash with eosinophilia and systemic symptoms (DRESS) syndrome Allergy Asthma Proc 33 2013 165 171
55. N. Dauby, W. Fink, L. Seyler, and et al. Probable hypersensitivity reaction to vancomycin associating rash, fever and neutropenia Acta Clin Belg 67 2012 226 228
56. P. O'Meara, R. Borici-Mazi, A.R. Morton, and A.K. Ellis DRESS with delayed onset acute interstitial nephritis and profound refractory eosinophilia secondary to Vancomycin Allergy Asthma Clin Immunol 7 2011 16
57. S. Boet, C. Noblet, C. Haas-Hubscher, D. Picard, P. Musette, and B. Dureuil Severe vancomycin-induced drug rash with eosinophilia and systemic symptoms syndrome imitating septic shock Eur J Anaesthesiol 26 2009 788 790
58. L. Vauthey, I. Uçkay, S. Abrassart, and et al. Vancomycin-induced DRESS syndrome in a female patient Pharmacology 82 2008 138 141
59. R. Tamagawa-Mineoka, N. Katoh, T. Nara, Y. Nishimura, S. Yamamoto, and S. Kishimoto DRESS syndrome caused by teicoplanin and vancomycin, associated with reactivation of human herpesvirus-6 Int J Dermatol 46 2007 654 655
60. E. Zuliani, H. Zwahlen, F. Gilliet, and C. Marone Vancomycin-induced hypersensitivity reaction with acute renal failure: resolution following cyclosporine treatment Clin Nephrol 64 2005 155 158
61. P.E. Marik, and N. Ferris Delayed hypersensitivity reaction to vancomycin Pharmacotherapy 17 1997 1341 1344
62. N.L. Htike, J. Santoro, B. Gilbert, I.B. Elfenbein, and G. Teehan Biopsy-proven vancomycin-associated interstitial nephritis and acute tubular necrosis Clin Exp Nephrol 16 2012 320 324
63. M.N. Salazar, M. Matthews, A. Posadas, M. Ehsan, and C. Graeber Biopsy proven interstitial nephritis following treatment with vancomycin: a case report Conn Med 74 3 2010 139 142
64. S. Michail, G. Vaiopoulos, L. Nakopoulou, and et al. Henoch-Schoenlein purpura and acute interstitial nephritis after intravenous vancomycin administration in a patient with a staphylococcal infection Scand J Rheumatol 27 1998 233 235
65. S. Hong, E. Valderrama, J. Mattana, and et al. Vancomycin-induced acute granulomatous interstitial nephritis: therapeutic options Am J Med Sci 334 2007 296 300
66. S.I. Hsu Biopsy-proved acute tubulointerstitial nephritis and toxic epidermal necrolysis associated with vancomycin Pharmacotherapy 21 2001 1233 1239
67. A.O. Wai, A.M. Lo, A. Abdo, and F. Marra Vancomycin-induced acute interstitial nephritis Ann Pharmacother 32 1998 1160 1164
68. C.E. Codding, L. Ramseyer, M. Allon, J. Pitha, and M. Rodriguez Tubulointerstitial nephritis due to vancomycin Am J Kidney Dis 14 1989 512 515
69. M. Bergman, R.H. Glew, and T.H. Ebert Acute interstitial nephritis associated with vancomycin therapy Arch Inter Med 148 1988 2139 2140
70. A. Changela, H. Javaiya, K. Rickenback, A. Elnawawi, and K. Changela Toxic epidermal necrolyis after vancomycin use: a case report and discussion of management Am J Ther 20 2013 223 225
71. J.D. Bouaziz, L. Valeyrie-Allanore, H. Damak, H. Faure, E. Marinho, and B. Regnier Toxic epidermal necrolysis after vancomycin in a patient with terminal renal insufficiency: interest for intensive haemodialysis? J Eur Acad Dermatol Venereol 20 2006 1011 1013
72. K. Chan-Tack Toxic epidermal necrolysis secondary to vancomycin Mo Med 97 2000 131 132
73. Alexander II, and P.A. Greenberger Vancomycin-induced Stevens-Johnson syndrome J Allergy Clin Immunol 17 1996 75 78
74. C. Vidal, A. González Quintela, and R. Fuente Toxic epidermal necrolysis due to vancomycin Ann Allergy 68 1992 345 347
75. Y. Sugimoto, Y. Iba, K. Utsugi, and C. Kamei Influences of everninomicin, vancomycin and teicoplanin on chemical mediator release from rat peritoneal mast cells Jpn J Pharmacol 83 2000 300 305
76. R.E. Polk, D. Israel, J. Wang, J. Venitz, J. Miller, and J. Stotka Vancomycin skin tests and prediction of "red man syndrome" in healthy volunteers Antimicrob Agents Chemother 37 1993 2139 2143
77. G. Fortuna, and M.P. Marinkovich Linear immunoglobulin A bullous dermatosis Clin Dermatol 30 2012 38 50
78. E.M. Mintz, and K.D. Morel Clinical features, diagnosis, and pathogenesis of chronic bullous disease of childhood Dermatol Clin 29 2011 459 462 ix
79. F. Wojnarowska, R.A. Marsden, B. Bhogal, and M.M. Black Chronic bullous disease of childhood, childhood cicatricial pemphigoid, and linear IgA disease of adults: a comparative study demonstrating clinical and immunopathologic overlap J Am Acad Dermatol 19 1988 792 805
80. P. Cacoub, P. Musette, V. Descamps, and et al. The DRESS syndrome: a literature review Am J Med 124 2011 588 597
81. S.H. Kardaun, P. Sekula, L. Valeyrie-Allanore, and et al. Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction: results from the prospective RegiSCAR study Br J Dermatol 169 2013 1071 1080
82. Y.-C. Chen, H.-C. Chiu, and C.-Y. Chu Drug reaction with eosinophilia and systemic symptoms: a retrospective study of 60 cases Arch Dermatol 146 2010 1373 1379
83. P. Wongkitisophon, K. Chanprapaph, P. Rattanakaemakorn, and V. Vachiramon Six-year retrospective review of drug reaction with eosinophilia and systemic symptoms Acta Derm Venereol 92 2012 200 205
84. S.J. Van Hal, D.L. Paterson, and T.P. Lodise Systematic review and meta-analysis of vancomycin-induced nephrotoxicity associated with dosing schedules that maintain troughs between 15 and 20 milligrams per liter Antimicrob Agents Chemother 57 2013 734 744
85. M.N. Jeffres, W. Isakow, J. Doherty, S.T. Micek, and M.H. Kollef A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumonia Clin Ther 29 2007 1107 1115
86. M. Perazella Diagnosing drug-induced AIN in the hospitalized patient: a challenge for the clinician Clin Nephrol 81 2014 381 388
87. M.J. Rybak, L.M. Albrecht, S.C. Boike, and P.H. Chandrasekar Nephrotoxicity of vancomycin, alone and with an aminoglycoside J Antimicrob Chemother 25 1990 679 687
88. J. Rossert Drug-induced acute interstitial nephritis Kidney Int 60 2001 804 817
89. Herbert A. Kirst, Diane G. Thompson, and T.I. Nicas Historical yearly usage of vancomycin Antimicrob Agents Chemother 42 1998 1303 1304